MIST — Milestone Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $89.82m
- $73.59m
- $1.00m
Annual cashflow statement for Milestone Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -55.2 | -50 | -42.9 | -58.4 | -59.7 |
| Depreciation | |||||
| Non-Cash Items | 1.19 | 4.95 | 7.28 | 9.09 | 11.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.85 | -5.81 | 2.26 | -3.26 | 1.24 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -51.2 | -50.7 | -33.2 | -52.5 | -46.4 |
| Capital Expenditures | -0.413 | — | — | -0.272 | -0.112 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.029 | -70 | 70 | -56.9 | 4.87 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.384 | -70 | 70 | -57.1 | 4.76 |
| Financing Cash Flow Items | — | — | — | — | -2.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 85.4 | 73.2 | 5.05 | 3.09 | 47.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33.9 | -47.5 | 41.8 | -107 | 6.12 |